Subsidies for drug firms with debts to health system
The government has approved 53 investment plans from pharmaceutical firms that owe payments for the public health service’s medical expenditures.
The investments, budgeted at €519. million, will be financed to the tune of €246.8 million from the EU’s Recovery and Resilience Facility.
Companies’ debts will be deducted from the subsidy.
Greek officials said Thursday that the investments will help create many new highly specialized jobs.
